GE HealthCare announced US FDA 510(k) clearance of Allia IGS Pulse – the latest addition to the company’s image guided system offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on GEHC:
- GE HealthCare announces new data from COSMOS Phase 1 study
- GE Healthcare (NASDAQ:GEHC) Lands Deal to Make AI-Powered Ultrasound Tech
- GE HealthCare in $44M deal with BARDA for AI applications to treat trauma
- Bentley Systems appoints Kristin Fallon as chief marketing officer
- GE HealthCare, University Hospitals enter ten-year strategic collaboration
